Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

442 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multinational study of pneumococcal serotypes causing acute otitis media in children.
Hausdorff WP, Yothers G, Dagan R, Kilpi T, Pelton SI, Cohen R, Jacobs MR, Kaplan SL, Levy C, Lopez EL, Mason EO Jr, Syriopoulou V, Wynne B, Bryant J. Hausdorff WP, et al. Among authors: wynne b. Pediatr Infect Dis J. 2002 Nov;21(11):1008-16. doi: 10.1097/00006454-200211000-00007. Pediatr Infect Dis J. 2002. PMID: 12442021
Efficacy and safety of pharmacokinetically enhanced amoxicillin-clavulanate at 2,000/125 milligrams twice daily for 5 days versus amoxicillin-clavulanate at 875/125 milligrams twice daily for 7 days in the treatment of acute exacerbations of chronic bronchitis.
Sethi S, Breton J, Wynne B. Sethi S, et al. Among authors: wynne b. Antimicrob Agents Chemother. 2005 Jan;49(1):153-60. doi: 10.1128/AAC.49.1.153-160.2005. Antimicrob Agents Chemother. 2005. PMID: 15616290 Free PMC article. Clinical Trial.
Efficacy of a new pharmacokinetically enhanced formulation of amoxicillin/clavulanate (2000/125 mg) in adults with community-acquired pneumonia caused by Streptococcus pneumoniae, including penicillin-resistant strains.
File TM, Garau J, Jacobs MR, Wynne B, Twynholm M, Berkowitz E. File TM, et al. Among authors: wynne b. Int J Antimicrob Agents. 2005 Feb;25(2):110-9. doi: 10.1016/j.ijantimicag.2004.10.007. Int J Antimicrob Agents. 2005. PMID: 15664480 Clinical Trial.
Outcome of treatment of respiratory tract infections due to Streptococcus pneumoniae, including drug-resistant strains, with pharmacokinetically enhanced amoxycillin/clavulanate.
File TM Jr, Jacobs MR, Poole MD, Wynne B; 546, 547, 548, 549, 550, 551, 556, 557 and 592 Clinical Study Groups. File TM Jr, et al. Among authors: wynne b. Int J Antimicrob Agents. 2002 Oct;20(4):235-47. doi: 10.1016/s0924-8579(02)00130-9. Int J Antimicrob Agents. 2002. PMID: 12385678 Clinical Trial.
Amoxicillin-clavulanic acid: additions and corrections.
Ackerman BH, Wynne B. Ackerman BH, et al. Among authors: wynne b. Mayo Clin Proc. 1999 Oct;74(10):1050-1. doi: 10.4065/74.10.1050. Mayo Clin Proc. 1999. PMID: 10918874 No abstract available.
442 results